Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients [Phase 4]
A Phase 4 trial evaluating switching to Tenofovir disoproxil fumarate versus continuing Lamivudine/Adefovir in lamivudine-resistant chronic …
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B [NA]
A completed trial compared the efficacy of combining Tenofovir with Telbivudine versus Tenofovir alone in patients with spontaneous reactiva…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients
This clinical trial update presents long-term results on the anti-HBV effects of tenofovir and resistance surveillance in Asian-American adu…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B [Phase 4]
Phase 4 follow-up study assessing long-term post-treatment effects of PEGASYS (peginterferon alfa-2a) in patients with HBeAg-positive chroni…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA [NA]
A prospective study evaluating the specificity of Roche's Cobas TaqScreen MPX test for detecting HBV DNA, HCV RNA, and HIV-1 RNA in plasma p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder [Phase 4]
Phase 4 trial evaluating long-term persistence of immunity to Hepatitis B in adolescents previously vaccinated in infancy with Engerix-B.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Study of Telbivudine in Chronic Hepatitis B
Clinical trial studying telbivudine for chronic hepatitis B has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus
A completed clinical trial evaluating early screening tools to monitor renal proximal tubular tolerance of nucleoside and nucleotide analogu…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection [Phase 2]
Phase 2 clinical trial assessing the efficacy of tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive patients co-infecte…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B [Phase 4]
Phase 4 study evaluating combination or sequential therapy with PEGASYS (peginterferon alfa-2a) and entecavir in HBeAg-positive chronic hepa…
-
CLINICAL_TRIALS withdrawal · 2016-02-22Clinical Trial Update: Chronic Hepatitis B and C Recall Northern Holland
A clinical trial in Northern Holland involving Hepatitis B and Hepatitis C is being recalled/withdrawn; status is currently UNKNOWN.
-
CLINICAL_TRIALS research · 2016-02-08Clinical Trial Update: A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines [NA]
This clinical trial update describes a study to characterize immune responses after immunisation with two Hepatitis B vaccines, Fendrix and …
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B [Phase 1]
A Phase I safety and tolerability study of birinapant in chronic hepatitis B was terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B [Phase 4]
A Phase 4 study evaluating the efficacy and safety of peginterferon alfa-2a (Pegasys) and adefovir dipivoxil (ADV) in lamivudine-resistant, …
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection [NA]
The document summarizes completion of a non-investigational study evaluating adenovirus serotype 5 neutralizing antibodies in patients with …
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients [Phase 3]
Phase 3 trial evaluating Niuliva® to prevent hepatitis B virus recurrence in liver transplant recipients. The study is completed with result…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B. [Phase 4]
Phase 4 study of PEGASYS (peginterferon alfa-2a) in HBeAg-positive chronic hepatitis B has completed and results have been posted.
-
CLINICAL_TRIALS withdrawal · 2016-01-18Clinical Trial Update: Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation [Phase 3]
Phase 3 trial of Nabi-HB given subcutaneously for chronic hepatitis B after liver transplantation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both [Phase 1]
Phase 1 trial in Asian patients with chronic hepatitis B evaluating early immunologic response to Pegasys or nucleoside analogues (or both);…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers [Phase 1]
Phase 1 bioequivalence study in healthy adults assessing the pharmacokinetics of Besifovir has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet [Phase 1]
Phase 1 study comparing the safety and pharmacokinetics of CKD-390 tablets with Viread tablets in chronic hepatitis B; the trial has complet…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination [Phase 3]
Phase 3 trial update reports antibody persistence at ages 3.5 and 4.5 years after primary and booster vaccination with DTaP-IPV-HepB-PRP~T o…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety and efficacy of REP 2139 (REP 9AC') in patients with chronic hepatitis B infection.
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the safety and efficacy of REP 9AC (REP 2055) in patients with chronic hepatitis B or hepatitis C…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides [Phase 4]
Phase 4 clinical trial update on adding pegylated interferon alfa-2a to chronic hepatitis B patients already treated with nucleos(t)ide anal…